Protein kinase CK2 phosphorylates the Nef protein from a neurovirulent simian immunodeficiency virus

Virology

Volumn 348, Issue 1, 2006, Pages 156-164

  Caples, Matthew J ^a   Clements, Janice E ^a   Barber, Sheila A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Nef; Neurovirulent; Protein kinase CK2; SIV

Indexed keywords

CASEIN KINASE II; NEF PROTEIN; PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN P21; PROTEIN SERINE KINASE; ENZYME INHIBITOR; PROTEIN KINASE; RECOMBINANT PROTEIN;

ARTICLE; DISEASE COURSE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN IMMUNODEFICIENCY VIRUS; MACROPHAGE; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRULENCE; AMINO ACID SUBSTITUTION; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; GENETICS; HUMAN; METABOLISM; MUTATION; PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS;

HUMAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS;

AMINO ACID SUBSTITUTION; CASEIN KINASE II; CELL LINE; ENZYME INHIBITORS; GENE PRODUCTS, NEF; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTATION; PHOSPHORYLATION; PROTEIN KINASES; RECOMBINANT PROTEINS; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 33744744354     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.12.028     Document Type: Article

References (75)

1. Aksenova M.V., Burbaeva G.S., Kandror K.V., Kapkov D.V., and Stepanov A.S. The decreased level of casein kinase 2 in brain cortex of schizophrenic and Alzheimer's disease patients. FEBS Lett. 279 1 (1991) 55-57
2. Alexander L., Illyinskii P.O., Lang S.M., Means R.E., Lifson J., Mansfield K., and Desrosiers R.C. Determinants of increased replicative capacity of serially passaged simian immunodeficiency virus with nef deleted in rhesus monkeys. J. Virol. 77 12 (2003) 6823-6835
3. Anderson M.G., Hauer D., Sharma D.P., Joag S.V., Narayan O., Zink M.C., and Clements J.E. Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques. Virology 195 2 (1993) 616-626
4. Arora V.K., Molina R.P., Foster J.L., Blakemore J.L., Chernoff J., Fredericksen B.L., and Garcia J.V. Lentivirus Nef specifically activates Pak2. J. Virol. 74 23 (2000) 11081-11087
5. Backer J.M., Mendola C.E., Fairhurst J.L., and Kovesdi I. The HIV-1 nef protein does not have guanine nucleotide binding, GTPase, or autophosphorylating activities. AIDS Res. Hum. Retroviruses 7 12 (1991) 1015-1020
6. Barber S.A., Flaherty M.T., Plafker S.M., and Clements J.E. A novel kinase activity associated with Nef derived from neurovirulent simian immunodeficiency virus. Virology 251 1 (1998) 165-175
7. Barber S.A., Maughan M.F., Roos J.W., and Clements J.E. Two amino acid substitutions in the SIV Nef protein mediate associations with distinct cellular kinases. Virology 276 2 (2000) 329-338
8. Battistutta R., De Moliner E., Sarno S., Zanotti G., and Pinna L.A. Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole. Protein Sci. 10 11 (2001) 2200-2206
9. Baur A.S., Sass G., Laffert B., Willbold D., Cheng-Mayer C., and Peterlin B.M. The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 6 3 (1997) 283-291
10. Bednar M.M., Kohut J.J., Kimelberg H.K., Gross J.J., and Gross C.E. In vitro evidence supporting two mechanisms of action for the anion transport inhibitor L-644,711 in cerebral ischaemia. Neurol. Res. 14 1 (1992) 53-56
11. Bildl W., Strassmaier T., Thurm H., Andersen J., Eble S., Oliver D., Knipper M., Mann M., Schulte U., Adelman J.P., and Fakler B. Protein kinase CK2 is coassembled with small conductance Ca(2+)-activated K+ channels and regulates channel gating. Neuron 43 6 (2004) 847-858
12. Blanquet P.R. Casein kinase 2 as a potentially important enzyme in the nervous system. Prog. Neurobiol. 60 3 (2000) 211-246
13. Blaydes J.P., and Hupp T.R. DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site. Oncogene 17 8 (1998) 1045-1052
14. Briggs S.D., Sharkey M., Stevenson M., and Smithgall T.E. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J. Biol. Chem. 272 29 (1997) 17899-17902
15. Carl S., Daniels R., Iafrate A.J., Easterbrook P., Greenough T.C., Skowronski J., and Kirchhoff F. Partial "repair" of defective NEF genes in a long-term nonprogressor with human immunodeficiency virus type 1 infection. J. Infect. Dis. 181 1 (2000) 132-140
16. Collette Y., Dutartre H., Benziane A., Ramos M., Benarous R., Harris M., and Olive D. Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects. J. Biol. Chem. 271 11 (1996) 6333-6341
17. Donella-Deana A., Cesaro L., Sarno S., Brunati A.M., Ruzzene M., and Pinna L.A. Autocatalytic tyrosine-phosphorylation of protein kinase CK2 alpha and alpha' subunits: implication of Tyr182. Biochem. J. 357 Pt 2 (2001) 563-567
18. Flaherty M.T., Hauer D.A., Mankowski J.L., Zink M.C., and Clements J.E. Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J. Virol. 71 8 (1997) 5790-5798
19. Flaherty M.T., Barber S.A., and Clements J.E. Neurovirulent simian immunodeficiency virus incorporates a Nef-associated kinase activity into virions. AIDS Res. Hum. Retroviruses 14 2 (1998) 163-170
20. Geleziunas R., Xu W., Takeda K., Ichijo H., and Greene W.C. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 410 6830 (2001) 834-838
21. Greenway A., Azad A., Mills J., and McPhee D. Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J. Virol. 70 10 (1996) 6701-6708
22. Greenway A.L., McPhee D.A., Allen K., Johnstone R., Holloway G., Mills J., Azad A., Sankovich S., and Lambert P. Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis. J. Virol. 76 6 (2002) 2692-2702
23. Haneda E., Furuya T., Asai S., Morikawa Y., and Ohtsuki K. Biochemical characterization of casein kinase II as a protein kinase responsible for stimulation of HIV-1 protease in vitro. Biochem. Biophys. Res. Commun. 275 2 (2000) 434-439
24. Harada S., Maekawa T., Haneda E., Morikawa Y., Nagata N., and Ohtsuki K. Biochemical characterization of recombinant HIV-1 reverse transcriptase (rRT) as a glycyrrhizin-binding protein and the CK-II-mediated stimulation of rRT activity potently inhibited by glycyrrhetinic acid derivative. Biol. Pharm. Bull. 21 12 (1998) 1282-1285
25. He J., deCastro C.M., Vandenbark G.R., Busciglio J., and Gabuzda D. Astrocyte apoptosis induced by HIV-1 transactivation of the c-kit protooncogene. Proc. Natl. Acad. Sci. U.S.A. 94 8 (1997) 3954-3959
26. Hu B.R., and Wieloch T. Casein kinase II activity in the postischemic rat brain increases in brain regions resistant to ischemia and decreases in vulnerable areas. J. Neurochem. 60 5 (1993) 1722-1728
27. Kestler H., Kodama T., Ringler D., Marthas M., Pedersen N., Lackner A., Regier D., Sehgal P., Daniel M., King N., et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248 4959 (1990) 1109-1112
28. Kestler III H.W., Ringler D.J., Mori K., Panicali D.L., Sehgal P.K., Daniel M.D., and Desrosiers R.C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65 4 (1991) 651-662
29. Kirchhoff F., Easterbrook P.J., Douglas N., Troop M., Greenough T.C., Weber J., Carl S., Sullivan J.L., and Daniels R.S. Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J. Virol. 73 7 (1999) 5497-5508
30. Koedel U., Kohleisen B., Sporer B., Lahrtz F., Ovod V., Fontana A., Erfle V., and Pfister H.W. HIV type 1 Nef protein is a viral factor for leukocyte recruitment into the central nervous system. J. Immunol. 163 3 (1999) 1237-1245
31. Kohleisen B., Shumay E., Sutter G., Foerster R., Brack-Werner R., Nuesse M., and Erfle V. Stable expression of HIV-1 Nef induces changes in growth properties and activation state of human astrocytes. AIDS 13 17 (1999) 2331-2341
32. Kort J.J., and Jalonen T.O. The nef protein of the human immunodeficiency virus type 1 (HIV-1) inhibits a large-conductance potassium channel in human glial cells. Neurosci. Lett. 251 1 (1998) 1-4
33. Kulartz M., Hiller E., Kappes F., Pinna L.A., and Knippers R. Protein kinase CK2 phosphorylates the cell cycle regulatory protein Geminin. Biochem. Biophys. Res. Commun. 315 4 (2004) 1011-1017
34. Lazaro J.B., Boretto J., Selmi B., Capony J.P., and Canard B. Phosphorylation of AZT-resistant human immunodeficiency virus type 1 reverse transcriptase by casein kinase II in vitro: effects on inhibitor sensitivity. Biochem. Biophys. Res. Commun. 275 1 (2000) 26-32
35. Letvin N.L., Daniel M.D., Sehgal P.K., Desrosiers R.C., Hunt R.D., Waldron L.M., MacKey J.J., Schmidt D.K., Chalifoux L.V., and King N.W. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230 4721 (1985) 71-73
36. Litchfield D.W. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem. J. 369 Pt 1 (2003) 1-15
37. Ljubimov A.V., Caballero S., Aoki A.M., Pinna L.A., Grant M.B., and Castellon R. Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization. Invest. Ophthalmol. Visual Sci. 45 12 (2004) 4583-4591
38. Mankowski J.L., Flaherty M.T., Spelman J.P., Hauer D.A., Didier P.J., Amedee A.M., Murphey-Corb M., Kirstein L.M., Munoz A., Clements J.E., and Zink M.C. Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J. Virol. 71 8 (1997) 6055-6060
39. Marin O., Meggio F., Sarno S., Cesaro L., Pagano M.A., and Pinna L.A. Tyrosine versus serine/threonine phosphorylation by protein kinase casein kinase-2. A study with peptide substrates derived from immunophilin Fpr3. J. Biol. Chem. 274 41 (1999) 29260-29265
40. Meggio F., Marin O., and Pinna L.A. Substrate specificity of protein kinase CK2. Cell. Mol. Biol. Res. 40 5-6 (1994) 401-409
41. Meggio F., D'Agostino D.M., Ciminale V., Chieco-Bianchi L., and Pinna L.A. Phosphorylation of HIV-1 Rev protein: implication of protein kinase CK2 and pro-directed kinases. Biochem. Biophys. Res. Commun. 226 2 (1996) 547-554
42. Meggio F., Marin O., Boschetti M., Sarno S., and Pinna L.A. HIV-1 Rev transactivator: a beta-subunit directed substrate and effector of protein kinase CK2. Mol. Cell. Biochem. 227 1-2 (2001) 145-151
43. Moarefi I., LaFevre-Bernt M., Sicheri F., Huse M., Lee C.H., Kuriyan J., and Miller W.T. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385 6617 (1997) 650-653
44. Naidu Y.M., Kestler III H.W., Li Y., Butler C.V., Silva D.P., Schmidt D.K., Troup C.D., Sehgal P.K., Sonigo P., Daniel M.D., et al. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac. J. Virol. 62 12 (1988) 4691-4696
45. Ohtsuki K., Maekawa T., Harada S., Karino A., Morikawa Y., and Ito M. Biochemical characterization of HIV-1 Rev as a potent activator of casein kinase II in vitro. FEBS Lett. 428 3 (1998) 235-240
46. Overholser E.D., Coleman G.D., Bennett J.L., Casaday R.J., Zink M.C., Barber S.A., and Clements J.E. Expression of simian immunodeficiency virus (SIV) nef in astrocytes during acute and terminal infection and requirement of nef for optimal replication of neurovirulent SIV in vitro. J. Virol. 77 12 (2003) 6855-6866
47. Pagano M.A., Andrzejewska M., Ruzzene M., Sarno S., Cesaro L., Bain J., Elliott M., Meggio F., Kazimierczuk Z., and Pinna L.A. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole. J. Med. Chem. 47 25 (2004) 6239-6247
48. Pagano M.A., Meggio F., Ruzzene M., Andrzejewska M., Kazimierczuk Z., and Pinna L.A. 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2. Biochem. Biophys. Res. Commun. 321 4 (2004) 1040-1044
49. Peter F. HIV nef: the mother of all evil?. Immunity 9 4 (1998) 433-437
50. Peudenier S., Hery C., Ng K.H., and Tardieu M. HIV receptors within the brain: a study of CD4 and MHC-II on human neurons, astrocytes and microglial cells. Res. Virol. 142 2-3 (1991) 145-149
51. Pinna L.A. Protein kinase CK2: a challenge to canons. J. Cell Sci. 115 Pt 20 (2002) 3873-3878
52. Ranki A., Nyberg M., Ovod V., Haltia M., Elovaara I., Raininko R., Haapasalo H., and Krohn K. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9 9 (1995) 1001-1008
53. Renkema G.H., and Saksela K. Interactions of HIV-1 NEF with cellular signal transducing proteins. Front. Biosci. 5 (2000) D268-D283
54. Richard A., Robichaud G., Lapointe R., Bourgoin S., Darveau A., and Poulin L. Interference of HIV-1 Nef in the sphingomyelin transduction pathway activated by tumour necrosis factor-alpha in human glial cells. AIDS 11 1 (1997) F1-F7
55. Robichaud G.A., and Poulin L. HIV type 1 nef gene inhibits tumor necrosis factor alpha-induced apoptosis and promotes cell proliferation through the action of MAPK and JNK in human glial cells. AIDS Res. Hum. Retroviruses 16 18 (2000) 1959-1965
56. Romero I.A., Teixeira A., Strosberg A.D., Cazaubon S., and Couraud P.O. The HIV-1 nef protein inhibits extracellular signal-regulated kinase-dependent DNA synthesis in a human astrocytic cell line. J. Neurochem. 70 2 (1998) 778-785
57. Saito Y., Sharer L.R., Epstein L.G., Michaels J., Mintz M., Louder M., Golding K., Cvetkovich T.A., and Blumberg B.M. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44 3 Pt 1 (1994) 474-481
58. Sarno S., Ghisellini P., and Pinna L.A. Unique activation mechanism of protein kinase CK2. The N-terminal segment is essential for constitutive activity of the catalytic subunit but not of the holoenzyme. J. Biol. Chem. 277 25 (2002) 22509-22514
59. Sarno S., Reddy H., Meggio F., Ruzzene M., Davies S.P., Donella-Deana A., Shugar D., and Pinna L.A. Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2'). FEBS Lett. 496 1 (2001) 44-48
60. Sawai E.T., Hamza M.S., Ye M., Shaw K.E., and Luciw P.A. Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef. J. Virol. 74 4 (2000) 2038-2045
61. Schubert U., Henklein P., Boldyreff B., Wingender E., Strebel K., and Porstmann T. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J. Mol. Biol. 236 1 (1994) 16-25
62. Schwartz E.I., Intine R.V., and Maraia R.J. CK2 is responsible for phosphorylation of human La protein serine-366 and can modulate rpL37 5′-terminal oligopyrimidine mRNA metabolism. Mol. Cell. Biol. 24 21 (2004) 9580-9591
63. Sharma D.P., Zink M.C., Anderson M., Adams R., Clements J.E., Joag S.V., and Narayan O. Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques. J. Virol. 66 6 (1992) 3550-3556
64. Smith B.L., Krushelnycky B.W., Mochly-Rosen D., and Berg P. The HIV nef protein associates with protein kinase C theta. J. Biol. Chem. 271 28 (1996) 16753-16757
65. Takahashi K., Wesselingh S.L., Griffin D.E., McArthur J.C., Johnson R.T., and Glass J.D. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann. Neurol. 39 6 (1996) 705-711
66. Thompson K.A., McArthur J.C., and Wesselingh S.L. Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann. Neurol. 49 6 (2001) 745-752
67. Tornatore C., Chandra R., Berger J.R., and Major E.O. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44 3 Pt 1 (1994) 481-487
68. Trillo-Pazos G., Diamanturos A., Rislove L., Menza T., Chao W., Belem P., Sadiq S., Morgello S., Sharer L., and Volsky D.J. Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol. 13 2 (2003) 144-154
69. van Marle G., Henry S., Todoruk T., Sullivan A., Silva C., Rourke S.B., Holden J., McArthur J.C., Gill M.J., and Power C. Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology 329 2 (2004) 302-318
70. Wallace M., Coates P.J., Wright E.G., and Ball K.L. Differential post-translational modification of the tumour suppressor proteins Rb and p53 modulate the rates of radiation-induced apoptosis in vivo. Oncogene 20 28 (2001) 3597-3608
71. Whatmore A.M., Cook N., Hall G.A., Sharpe S., Rud E.W., and Cranage M.P. Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J. Virol. 69 8 (1995) 5117-5123
72. Wilson L.K., Benton B.M., Zhou S., Thorner J., and Martin G.S. The yeast immunophilin Fpr3 is a physiological substrate of the tyrosine-specific phosphoprotein phosphatase Ptp1. J. Biol. Chem. 270 42 (1995) 25185-25193
73. Xu X.N., Laffert B., Screaton G.R., Kraft M., Wolf D., Kolanus W., Mongkolsapay J., McMichael A.J., and Baur A.S. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J. Exp. Med. 189 9 (1999) 1489-1496
74. Zanotto P.M., Kallas E.G., de Souza R.F., and Holmes E.C. Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics 153 3 (1999) 1077-1089
75. Zegarra-Moran O., Rasola A., Rugolo M., Porcelli A.M., Rossi B., and Galietta L.J. HIV-1 nef expression inhibits the activity of a Ca2+-dependent K+ channel involved in the control of the resting potential in CEM lymphocytes. J. Immunol. 162 9 (1999) 5359-5366